Sonoporation-mediated anti-angiogenic gene transfer into muscle effectively regresses distant orthotopic tumors

Z. K. Liao, K. C. Tsai, H. T. Wang, S. H. Tseng, W. P. Deng, W. S. Chen, L. H. Hwang

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Ultrasound (US) is an effective tool for local delivery of genes into target tumors or organs. In combination with microbubbles, US can temporarily change the permeability of cell membranes by cavitation and facilitate entry of plasmid DNA into cells. Here, we demonstrate that repeated US-mediated delivery of anti-angiogenic genes, endostatin or calreticulin, into muscle significantly inhibits the growth of orthotopic tumors in the liver, brain or lung. US-mediated anti-angiogenic gene therapy also seems to function as an adjuvant therapy that significantly enhances the antitumor effects of the chemotherapeutic drug doxorubicin and adenovirus-mediated cytokine gene therapy. Significantly higher levels of tumor apoptosis or tumor-infiltrating lymphocytes were observed after combined therapy consisting of either anti-angiogenic therapy and chemotherapy, or anti-angiogenic therapy and immunotherapy. Taken together, our experiments demonstrate that intramuscular delivery of anti-angiogenic genes by US exposure can effectively treat distant orthotopic tumors, and thus has great therapeutic potential in terms of clinical treatment.

Original languageEnglish
Pages (from-to)171-180
Number of pages10
JournalCancer Gene Therapy
Volume19
Issue number3
DOIs
Publication statusPublished - Mar 2012

Fingerprint

Muscles
Genes
Neoplasms
Genetic Therapy
Therapeutics
Endostatins
Cell Membrane Permeability
Calreticulin
Tumor-Infiltrating Lymphocytes
Microbubbles
Adenoviridae
Immunotherapy
Doxorubicin
Plasmids
Apoptosis
Cytokines
Drug Therapy
Lung
Liver
DNA

Keywords

  • anti-angiogenic gene therapy
  • orthotopic tumors
  • sonoporation
  • ultrasound

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Medicine
  • Molecular Biology

Cite this

Sonoporation-mediated anti-angiogenic gene transfer into muscle effectively regresses distant orthotopic tumors. / Liao, Z. K.; Tsai, K. C.; Wang, H. T.; Tseng, S. H.; Deng, W. P.; Chen, W. S.; Hwang, L. H.

In: Cancer Gene Therapy, Vol. 19, No. 3, 03.2012, p. 171-180.

Research output: Contribution to journalArticle

Liao, Z. K. ; Tsai, K. C. ; Wang, H. T. ; Tseng, S. H. ; Deng, W. P. ; Chen, W. S. ; Hwang, L. H. / Sonoporation-mediated anti-angiogenic gene transfer into muscle effectively regresses distant orthotopic tumors. In: Cancer Gene Therapy. 2012 ; Vol. 19, No. 3. pp. 171-180.
@article{dcc655973ff84612ae2b9b772c88fbcc,
title = "Sonoporation-mediated anti-angiogenic gene transfer into muscle effectively regresses distant orthotopic tumors",
abstract = "Ultrasound (US) is an effective tool for local delivery of genes into target tumors or organs. In combination with microbubbles, US can temporarily change the permeability of cell membranes by cavitation and facilitate entry of plasmid DNA into cells. Here, we demonstrate that repeated US-mediated delivery of anti-angiogenic genes, endostatin or calreticulin, into muscle significantly inhibits the growth of orthotopic tumors in the liver, brain or lung. US-mediated anti-angiogenic gene therapy also seems to function as an adjuvant therapy that significantly enhances the antitumor effects of the chemotherapeutic drug doxorubicin and adenovirus-mediated cytokine gene therapy. Significantly higher levels of tumor apoptosis or tumor-infiltrating lymphocytes were observed after combined therapy consisting of either anti-angiogenic therapy and chemotherapy, or anti-angiogenic therapy and immunotherapy. Taken together, our experiments demonstrate that intramuscular delivery of anti-angiogenic genes by US exposure can effectively treat distant orthotopic tumors, and thus has great therapeutic potential in terms of clinical treatment.",
keywords = "anti-angiogenic gene therapy, orthotopic tumors, sonoporation, ultrasound",
author = "Liao, {Z. K.} and Tsai, {K. C.} and Wang, {H. T.} and Tseng, {S. H.} and Deng, {W. P.} and Chen, {W. S.} and Hwang, {L. H.}",
year = "2012",
month = "3",
doi = "10.1038/cgt.2011.73",
language = "English",
volume = "19",
pages = "171--180",
journal = "Cancer Gene Therapy",
issn = "0929-1903",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Sonoporation-mediated anti-angiogenic gene transfer into muscle effectively regresses distant orthotopic tumors

AU - Liao, Z. K.

AU - Tsai, K. C.

AU - Wang, H. T.

AU - Tseng, S. H.

AU - Deng, W. P.

AU - Chen, W. S.

AU - Hwang, L. H.

PY - 2012/3

Y1 - 2012/3

N2 - Ultrasound (US) is an effective tool for local delivery of genes into target tumors or organs. In combination with microbubbles, US can temporarily change the permeability of cell membranes by cavitation and facilitate entry of plasmid DNA into cells. Here, we demonstrate that repeated US-mediated delivery of anti-angiogenic genes, endostatin or calreticulin, into muscle significantly inhibits the growth of orthotopic tumors in the liver, brain or lung. US-mediated anti-angiogenic gene therapy also seems to function as an adjuvant therapy that significantly enhances the antitumor effects of the chemotherapeutic drug doxorubicin and adenovirus-mediated cytokine gene therapy. Significantly higher levels of tumor apoptosis or tumor-infiltrating lymphocytes were observed after combined therapy consisting of either anti-angiogenic therapy and chemotherapy, or anti-angiogenic therapy and immunotherapy. Taken together, our experiments demonstrate that intramuscular delivery of anti-angiogenic genes by US exposure can effectively treat distant orthotopic tumors, and thus has great therapeutic potential in terms of clinical treatment.

AB - Ultrasound (US) is an effective tool for local delivery of genes into target tumors or organs. In combination with microbubbles, US can temporarily change the permeability of cell membranes by cavitation and facilitate entry of plasmid DNA into cells. Here, we demonstrate that repeated US-mediated delivery of anti-angiogenic genes, endostatin or calreticulin, into muscle significantly inhibits the growth of orthotopic tumors in the liver, brain or lung. US-mediated anti-angiogenic gene therapy also seems to function as an adjuvant therapy that significantly enhances the antitumor effects of the chemotherapeutic drug doxorubicin and adenovirus-mediated cytokine gene therapy. Significantly higher levels of tumor apoptosis or tumor-infiltrating lymphocytes were observed after combined therapy consisting of either anti-angiogenic therapy and chemotherapy, or anti-angiogenic therapy and immunotherapy. Taken together, our experiments demonstrate that intramuscular delivery of anti-angiogenic genes by US exposure can effectively treat distant orthotopic tumors, and thus has great therapeutic potential in terms of clinical treatment.

KW - anti-angiogenic gene therapy

KW - orthotopic tumors

KW - sonoporation

KW - ultrasound

UR - http://www.scopus.com/inward/record.url?scp=84857113870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857113870&partnerID=8YFLogxK

U2 - 10.1038/cgt.2011.73

DO - 10.1038/cgt.2011.73

M3 - Article

C2 - 22095386

AN - SCOPUS:84857113870

VL - 19

SP - 171

EP - 180

JO - Cancer Gene Therapy

JF - Cancer Gene Therapy

SN - 0929-1903

IS - 3

ER -